Susquehanna International Group’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-183,400
| Closed | -$270K | – | 14810 |
|
|
2022
Q2 | $270K | Buy |
183,400
+81,400
| +80% | +$59.8K | ﹤0.01% | 9855 |
|
|
2022
Q1 | $117K | Sell |
102,000
-29,400
| -22% | -$47.9K | ﹤0.01% | 11789 |
|
|
2021
Q4 | $329K | Buy |
131,400
+71,600
| +120% | +$281K | ﹤0.01% | 10256 |
|
|
2021
Q3 | $306K | Sell |
59,800
-12,100
| -17% | -$73.5K | ﹤0.01% | 10564 |
|
|
2021
Q2 | $597K | Buy |
71,900
+45,200
| +169% | +$381K | ﹤0.01% | 9169 |
|
|
2021
Q1 | $233K | Buy |
26,700
+3,500
| +15% | +$36.2K | ﹤0.01% | 11125 |
|
|
2020
Q4 | $252K | Sell |
23,200
-60,400
| -72% | -$745K | ﹤0.01% | 9628 |
|
|
2020
Q3 | $997K | Sell |
83,600
-40,300
| -33% | -$540K | ﹤0.01% | 6127 |
|
|
2020
Q2 | $1.99M | Sell |
123,900
-11,600
| -9% | -$202K | ﹤0.01% | 4507 |
|
|
2020
Q1 | $2.1M | Buy |
135,500
+8,500
| +7% | +$183K | ﹤0.01% | 3886 |
|
|
2019
Q4 | $3.12M | Buy |
127,000
+116,700
| +1,133% | +$1.73M | ﹤0.01% | 3638 |
|
|
2019
Q3 | $106K | Sell |
10,300
-18,300
| -64% | -$231K | ﹤0.01% | 9538 |
|
|
2019
Q2 | $359K | Buy |
28,600
+11,000
| +63% | +$142K | ﹤0.01% | 7950 |
|
|
2019
Q1 | $218K | Buy |
+17,600
| New | +$197K | ﹤0.01% | 7756 |
|
|
2018
Q3 | – | Sell |
-26,000
| Closed | -$352K | – | 10556 |
|
|
2018
Q2 | $352K | Buy |
26,000
+13,200
| +103% | +$205K | ﹤0.01% | 7525 |
|
|
2018
Q1 | $227K | Sell |
12,800
-67,700
| -84% | -$1.14M | ﹤0.01% | 8119 |
|
|
2017
Q4 | $1.01M | Buy |
80,500
+69,900
| +659% | +$1.02M | ﹤0.01% | 5209 |
|
|
2017
Q3 | $202K | Sell |
10,600
-19,900
| -65% | -$304K | ﹤0.01% | 8004 |
|
|
2017
Q2 | $461K | Buy |
+30,500
| New | +$461K | ﹤0.01% | 6800 |
|
|
2017
Q1 | – | Sell |
-78,700
| Closed | -$952K | – | 10312 |
|
|
2016
Q4 | $952K | Sell |
78,700
-14,200
| -15% | -$148K | ﹤0.01% | 5635 |
|
|
2016
Q3 | $914K | Buy |
+92,900
| New | +$848K | ﹤0.01% | 4972 |
|
|
2015
Q4 | – | Sell |
-111,500
| Closed | -$1.43M | – | 10169 |
|
|
2015
Q3 | $1.43M | Buy |
111,500
+87,400
| +363% | +$1.76M | ﹤0.01% | 4975 |
|
|
2015
Q2 | $578K | Buy |
24,100
+8,100
| +51% | +$156K | ﹤0.01% | 7335 |
|
|
2015
Q1 | $300K | Buy |
+16,000
| New | +$330K | ﹤0.01% | 7979 |
|
Other funds holding EPZM
Susquehanna International Group's EPZM Position: Q3 2022 in Review
Susquehanna International Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 184,964 shares — an estimated $272K sold.
Susquehanna International Group first reported a position in EPZM in Q2 2013 and held it in 19 quarters. The position peaked at $2.73M in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Susquehanna International Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Susquehanna International Group sold 184,964 Epizyme, Inc shares in Q3 2022, an estimated $272K.
- Susquehanna International Group first reported a position in Epizyme, Inc in Q2 2013 and held it in 19 quarters.
- Susquehanna International Group's Epizyme, Inc position peaked at $2.73M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.